Theralase Technologies Inc. TLTFF

Primary Symbol: V.TLT

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > First step of many big steps...

<< Previous

Bullboard Posts

Next >>

Comment by TimboBagginson Nov 12, 2024 1:25pm

114 Views

Post# 36308595

RE:RE:RE:RE:RE:First step of many big steps...

Infinity wrote: Menoalittle. Can you share your source of info. If PP is closed they should disclose. I think holding back information from share holders does not meet SEC regulations.

They're not holding it back, this is how it has always worked. It closes, they get approval the next week, they disclose the next week. It's only been done 10 times now.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant